Tag: rvl pharmaceuticals

All

RVL Pharmaceuticals reported 22% revenue growth for Upneeq in Q3 2025 and announced leadership changes to support continued expansion of the product.

Researchers found participation among underrepresented racial and ethnic groups increased far beyond national population growth.